PocketEdge
PocketEdge
NewsResearchPortfolioAdvisorsGuidesToolsAI
Ask AI
PocketEdge

Markets, research, advisors, guides, and tools. Understand what is happening, and what to do next.

Explore

  • News
  • Research
  • Advisors
  • Guides
  • Tools
  • Ask AI

© 2026 PocketEdge

PrivacyTermsLegal

Not investment advice. Verify with licensed professionals.

Company research memos

55 hand-built midcap memos. Filter by verdict, industry, or company. Short news desk notes live under News.

Clear
Clear all

Filters

Clear

Verdict

Industry

Company

1 memo of 55

avoid

ASTEC · Agrochemicals

Astec LifeSciences: leveraged agchem turnaround priced ahead of base recovery

FY26 revenue rebounded but PAT loss near ₹81 cr; at ₹709 base FY27E implies ~85% downside, Avoid.

25 min · Yesterday